Caleb AppletoninBison VenturesOur investment in Vivodyne and its vision to make fewer drugs failRecent years have seen breakthrough therapeutic success ushered in by new and emergent drug modalities. Since 2017 eight fundamentally new…Nov 22, 2023Nov 22, 2023